Feiya Du
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
Papers in
-
- Circular RNAs in diseases 2
- RNA modifications and cancer 2
- Metabolism, Diabetes, and Cancer 1
-
- MicroRNA in disease regulation 3
- Cancer, Hypoxia, and Metabolism 3
- Cancer-related molecular mechanisms research 2
- Co-authors
- Minya Yao (7 shared papers)Peifen Fu (6 shared papers)Kezhen Lv (4 shared papers)Binghe Xu (1 shared paper)Fangchao Zheng (1 shared paper)Jun Zhao (1 shared paper)Guoshuang Shen (1 shared paper)Yu Liu (2 shared papers)
- Journals
- Aesthetic Plastic Surgery (2 papers)Cell Death and Disease (2 papers)Current Cancer Drug Targets (1 paper)Journal of Cosmetic and Laser Therapy (1 paper)Oncology Reports (1 paper)
- Partner nations
- ChinaMadagascarUkraine
In The Last Decade
Feiya Du
15 papers receiving 426 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 199
- Molecular Biology 284
- Dermatology 33
- Oncology 80
- Complementary and alternative medicine 22
Countries citing papers authored by Feiya Du
This map shows the geographic impact of Feiya Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feiya Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feiya Du more than expected).
Fields of papers citing papers by Feiya Du
This network shows the impact of papers produced by Feiya Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feiya Du. The network helps show where Feiya Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Feiya Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 94 | |
| 2 | 2019 | 62 | |
| 3 | 2014 | 41 | |
| 4 | 2015 | 36 | |
| 5 | 2013 | 33 | |
| 6 | WP1130 increases cisplatin sensitivity through inhibition of usp9x in estrogen receptor-negative breast cancer cells. | 2017 | 30 |
| 7 | 2014 | 29 | |
| 8 | 2014 | 27 | |
| 9 | 2015 | 21 | |
| 10 | 2015 | 13 | |
| 11 | 2012 | 11 | |
| 12 | 2017 | 11 | |
| 13 | Wogonin increases doxorubicin sensitivity by down-regulation of IGF-1R/AKT signaling pathway in human breast cancer. | 2015 | 9 |
| 14 | 2023 | 9 | |
| 15 | [Fisheries biology of Nemipterus bathybius and its optimum catchable size in northern South China Sea]. | 2005 | 2 |
| 16 | 2024 | 0 |
About Feiya Du
Feiya Du is a scholar working on Molecular Biology, Cancer Research, Dermatology, Surgery and Oncology, having authored 16 papers that have together received 428 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Dermatologic Treatments and Research (2 papers), Cancer-related molecular mechanisms research (2 papers), Circular RNAs in diseases (2 papers), Laser Applications in Dentistry and Medicine (2 papers), RNA modifications and cancer (2 papers) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Cancer Research (199 citations), Molecular Biology (284 citations), Dermatology (33 citations), Oncology (80 citations) and Complementary and alternative medicine (22 citations). Feiya Du has collaborated with scholars based in China, Madagascar and Ukraine. Frequent co-authors include Minya Yao, Peifen Fu, Kezhen Lv, Binghe Xu, Fangchao Zheng, Jun Zhao, Guoshuang Shen, Yu Liu, Shusen Zheng and Yu Liu. Their work appears in journals such as Aesthetic Plastic Surgery, Cell Death and Disease, Current Cancer Drug Targets, Journal of Cosmetic and Laser Therapy and Oncology Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.